Kristel Wittebols

998 total citations
14 papers, 728 citations indexed

About

Kristel Wittebols is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kristel Wittebols has authored 14 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kristel Wittebols's work include Coronary Interventions and Diagnostics (13 papers), Peripheral Artery Disease Management (6 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). Kristel Wittebols is often cited by papers focused on Coronary Interventions and Diagnostics (13 papers), Peripheral Artery Disease Management (6 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). Kristel Wittebols collaborates with scholars based in Netherlands, Germany and Italy. Kristel Wittebols's co-authors include Antonio Colombo, Bernard De Bruyne, Patrick W. Serruys, Christian W. Hamm, Hans Peter Stoll, Pascal Vranckx, Monique Schuijer, Tessa Rademaker, Giulio Guagliumi and Carlos Macaya and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Kristel Wittebols

14 papers receiving 692 citations

Peers

Countries citing papers authored by Kristel Wittebols

Since Specialization

Citations

This map shows the geographic impact of Kristel Wittebols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristel Wittebols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristel Wittebols more than expected).

Fields of papers citing papers by Kristel Wittebols

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristel Wittebols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristel Wittebols. The network helps show where Kristel Wittebols may publish in the future.

Co-authorship network of co-authors of Kristel Wittebols

This figure shows the co-authorship network connecting the top 25 collaborators of Kristel Wittebols. A scholar is included among the top collaborators of Kristel Wittebols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristel Wittebols. Kristel Wittebols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	One‐Year Results of the CRISTAL Trial, a Randomized Comparison of Cypher Sirolimus‐Eluting Coronary Stents versus Balloon Angioplasty for Restenosis of Drug‐Eluting Stents 2012 ·Journal of Interventional Cardiology ·Bernard Chevalier, (unknown), Emmanuel Teíger, Philippe Brunel, Jean‐Philippe Metzger, Michel Pansiéri, Didier Carrié, Hans-Peter Stoll, Kristel Wittebols, Christian Spaulding, Jean Fajadet, (unknown)	22
2	Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II) 2011 ·EuroIntervention ·Victor Legrand, Scot Garg, Patrick W. Serruys, Kari Virtanen, (unknown), Vassilis Voudris, Alessandro Fontanelli, (unknown), (unknown), Tessa Rademaker, (unknown), Kristel Wittebols	9
3	5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions 2010 ·Journal of the American College of Cardiology ·Patrick W. Serruys, Yoshinobu Onuma, Scot Garg, Pascal Vranckx, Bernard De Bruyne, Marie‐Claude Morice, Antonio Colombo, Carlos Macaya, Gert Richardt, Jean Fajadet, Christian W. Hamm, Monique Schuijer, Tessa Rademaker, Kristel Wittebols, Hans Peter Stoll	177
4	Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease 2010 ·EuroIntervention ·Ron van Domburg, Joost Daemen, Marie-Claude Morice, Bernard De Bruyne, Antonio Colombo, Carlos Macaya, Gert Richardt, Jean Fajadet, Christian W. Hamm, Gerrit-Anne van Es, Kristel Wittebols, Nathalie Macours, Hans Peter Stoll, Patrick W. Serruys	19
5	Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II) 2009 ·EuroIntervention ·Helen Routledge, Thierry Lefèvre, Antonio Colombo, (unknown), Christian Hamm, Giulio Guagliumi, Wolfgang von Scheidt, Victor Guetta, Witold Rużyłło, Kristel Wittebols, Dick Goedhart, Patrick W. Serruys	15
6	Multivessel Coronary Revascularization in Patients With and Without Diabetes Mellitus 2008 ·Journal of the American College of Cardiology ·Joost Daemen, Karl Heinz Kuck, Carlos Macaya, Victor Legrand, (unknown), Didier Carrié, Imad Sheiban, Maarten J. Suttorp, Pascal Vranckx, Tessa Rademaker, Dick Goedhart, Monique Schuijer, Kristel Wittebols, Nathalie Macours, Hans Peter Stoll, Patrick W. Serruys	85
7	Three-year follow-up of the ARTS-II# – sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease 2008 ·EuroIntervention ·Patrick W. Serruys, Joost Daemen, Marie‐Claude Morice, Bernard De Bruyne, Antonio Colombo, Carlos Macaya, Gert Richardt, Jean Fajadet, Christian W. Hamm, Keith D. Dawkins, Pascal Vranckx, Marco Bressers, Ron van Domburg, Monique Schuijer, Kristel Wittebols, (unknown), Hans Peter Stoll	34
8	Impact of Body Mass Index on the One-Year Clinical Outcome of Patients Undergoing Multivessel Revascularization With Sirolimus-Eluting Stents (from the Arterial Revascularization Therapies Study Part II)††Conflicts of interest: Magdaleen Pieters, Kristel Wittebols, and Hans-Peter Stoll are employees of Cordis Corporation. Joost Daemen received a consultancy fee for his scientific contribution. 2008 ·The American Journal of Cardiology ·Ahmed A. Khattab, Joost Daemen, Gert Richardt, Philippe Rioux, (unknown), Richard Lévy, Iván Horváth, Rui Campante Teles, (unknown), (unknown), Kristel Wittebols, Hans-Peter Stoll, Patrick W. Serruys	10
9	Cyphering the Complexity of Coronary Artery Disease Using the Syntax Score to Predict Clinical Outcome in Patients With Three-Vessel Lumen Obstruction Undergoing Percutaneous Coronary Intervention 2007 ·The American Journal of Cardiology ·Marco Valgimigli, Patrick Washington Serruys, Keiichi Tsuchida, Sophia Vaina, Marie-angèle Morel, Marcel J. van den Brand, Antonio Colombo, Marie Claude Morice, Keith D. Dawkins, Bernard De Bruyne, Ran Kornowski, Stefano De Servi, Giulio Guagliumi, J. Wouter Jukema, (unknown), A. Pieter Kappetein, Kristel Wittebols, Hans-Peter Stoll, Eric Boersma, Giovanni Parrinello	232
10	The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II) 2007 ·European Heart Journal ·K. Tsuchida, Antonio Colombo, (unknown), Keith G. Oldroyd, Victor Guetta, Giulio Guagliumi, Wolfgang von Scheidt, (unknown), Christian W. Hamm, Marco Bressers, Hans‐Peter Stoll, Kristel Wittebols, Dennis Donohoe, Patrick W. Serruys	83
11	Impact of Stable Versus Unstable Coronary Artery Disease on 1-Year Outcome in Elective Patients Undergoing Multivessel Revascularization With Sirolimus-Eluting Stents 2007 ·Journal of the American College of Cardiology ·Marco Valgimigli, Keith D. Dawkins, Carlos Macaya, Bernard De Bruyne, Emmanuel Teíger, Jean Fajadet, Gert Richardt, Stefano De Servi, Angelo Ramondo, Kristel Wittebols, Hans-Peter Stoll, Tessa Rademaker, Patrick W. Serruys	18
12	Abstract 2150: A European and Canadian Multicenter Randomized, Double-Blind Trial of the Sirolimus-Eluting Stent (SES) in Patients with De Novo Native Coronary Artery Lesions (NEW-SIRIUS): 5-Year Clinical Outcomes 2007 ·Circulation ·(unknown), Joachim Schöfer, (unknown), Eric A. Cohen, Michael Schlüter, Thomas Wichter, Kristel Wittebols, Hans‐Peter Stoll	2
13	One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease. 2006 ·EuroIntervention ·Carlos Macaya, (unknown), (unknown), (unknown), (unknown), (unknown), Imad Sheiban, (unknown), (unknown), (unknown), Kristel Wittebols, (unknown), (unknown), Marco Bressers, (unknown)	4
14	One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-I. 2006 ·PubMed ·Carlos Macaya, Héctor M. García‐García, Antonio Colombo, Marie‐Claude Morice, Victor Legrand, Karl‐Heinz Kück, Imad Sheiban, Maarten J. Suttorp, Didier Carrié, Mathias Vrolix, Kristel Wittebols, Hans‐Peter Stoll, Dennis Donohoe, Marco Bressers, Patrick W. Serruys	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact